Skip to main content
Close
Vilcek Foundation
  • About
    • About

      The Vilcek Foundation raises awareness of immigrant contributions in the United States and fosters appreciation of the arts and sciences.

    • Our Mission
    • Board & Staff
    • Press Center
    • Contact
  • Prizes
    • Prizes

      The Vilcek Foundation Prizes are awarded to foreign-born individuals for extraordinary achievement in the arts and sciences.

    • About the Prizes

      Learn more about the Vilcek Foundation Prizes and the prizewinners.

    • Vilcek Prizes

      Awarded to immigrants with a legacy of major accomplishments.

    • Vilcek Prizes for Creative Promise

      Awarded to young immigrant professionals who have demonstrated outstanding achievement early in their careers.

    • Vilcek Prize for Excellence

      Awarded to immigrants who have had a significant impact on American society, or to individuals who are dedicated champions of immigrant causes.

    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
Sign Up Search
Home > News > Silvi Rouskin: “The pandemic has been an extreme cause for speed and urgency”

Silvi Rouskin: “The pandemic has been an extreme cause for speed and urgency”

News | February 8, 2021
Tags
covid-19 MIT rna sars-cov2 virology viruses Whitehead Institute
Share this page
Twitter Facebook LinkedIn

Silvi Rouskin standing on a Boston city street.

Molecular biologist Silvi Rouskin is driven to understand what enables RNA viruses to be so destructive, particularly given their minuscule physical size and the length of their genomes compared to their human hosts. “Those are fundamental questions that we don’t understand and are very important,” Silvi says, “because viruses will always be around and they’ll always be a threat to human health.”

Born in Sofia, Bulgaria, to musician parents, Silvi describes her younger self as “the nerdy kid of the rock stars in the neighborhood.” Her parents’ unconventional lifestyle provided Silvi with a powerful model of nonconformity and the value of independence. “I got from [them] that you can push the envelope—that you can do impossible things,” says Silvi. “My mom would always say, ‘It’s OK if there’s no precedent. You’re going to be the precedent.’”

Silvi is fiercely independent; she questions authority, and seeks deeper answers and understanding in all of her research and investigations. Feeling stifled by the education system in Bulgaria, Silvi moved to the United States on her own at the age of 15 as a high school exchange student. “Regardless of your background, if you have enough passion and if you’re good enough and if you try hard enough, [the United States is] this place where you can make anything happen.”

The democratic nature of schooling and scientific inquiry that Silvi encountered in the United States catalyzed her drive to pursue higher education and a career in science. Within a year of arriving in the United States, Silvi studied to take the GED so that she could apply to college early. At the age of 16, she was accepted into the Florida Institute of Technology with a generous scholarship.

Silvi Rouskin points to a scientific equipment monitor while a lab student looks on.

Now a fellow at the Whitehead Institute, Silvi continues to push the envelope. The Rouskin lab was one of the first in the United States that began to study the SARS-CoV-2 virus in the spring of 2020. “The pandemic has been an extreme cause for speed and urgency in the lab.” Silvi recalls, “We wanted to work as fast as possible because we didn’t know how bad it [was] going to be.”

Her lab’s current research seeks to examine ways that the biomolecule’s structure could be targeted by potential therapies or interventions. “Once we know all the different shapes that this viral RNA can form, and we understand the chemistry of them, then we can also develop small molecules that can bind to them and interfere with infection,” she says. “Our research can really matter right now. And right now is the moment where we can make a difference.”

Silvi Rouskin writes on a whiteboard against a Boston city backdrop.

“That’s our dream,” says Silvi. “To understand the basic fundamental chemical and biophysical principles that will allow us to design new [therapies] against new viruses…. I want my work to matter. I hope that, based on our work, one day we would be able to prevent pandemics like the one we’re having now.”

A graduate of the Florida Institute of Technology and the University of California San Francisco, Silvi was the recipient of 2020 awards from the Chan Zuckerberg Initiative and the Pershing Square Foundation. She receives a Vilcek Prize for Creative Promise in Biomedical Science for her groundbreaking work exploring the structures of viral RNA, aiding the potential development of RNA-based therapeutics for HIV and COVID-19.

Tags
covid-19 MIT rna sars-cov2 virology viruses Whitehead Institute
Share this page
Twitter Facebook LinkedIn

Related News

February 22, 2021

Ruth Lehmann: “There’s always another question… there’s always more to find out”

Molecular and cellular biologist Ruth Lehmann receives the Vilcek Prize in Biomedical Science for her research and leadership in the field.
A portrait of Ruth Lehmann in a black blazer as she stands on a bridge over the Charles River.
March 29, 2022

Katalin Karikó: The sacrifices and successes of immigrant scientists

Amid multiple awards for the development of mRNA vaccines, Hungarian biochemist Katalin Karikó insists that her greatest success has been being able to show up every day for a career she is passionate about.
Katalin Karikó standing in the woods in a beige coat with fur trim.
June 8, 2021

Vilcek Foundation awards $100,000 prize to Dr. Katalin Karikó, immigrant scientist who pioneered mRNA vaccine technology

Dr. Katalin Karikó receives the 2022 Vilcek Prize for Excellence in Biotechnology.
Katalin Karikó sits in her home office dressed in a black blazer.

You may also be interested in

Silvi Rouskin

Silvi Rouskin receives the Vilcek Prize for Creative Promise in Biomedical Science for developing methods to unravel the shapes of RNA molecules inside cells and aiding the potential development of RNA-based therapeutics.
Portrait of Silvi Rouskin

Ruth Lehmann

Ruth Lehmann receives the Vilcek Prize in Biomedical Science for unraveling the molecular basis by which germ cells, which give rise to sperm and egg cells, are formed.
Portrait of Ruth Lehmann

Katalin Karikó

Katalin Karikó receives the Vilcek Prize for Excellence in Biotechnology for her pioneering research leadership into the development of mRNA therapeutics, which led to the development of mRNA vaccines for COVID-19.
Portrait of Katalin Karikó

Join our mailing list

Sign Up
Vilcek Foundation
21 East 70th Street
New York, New York 10021

Phone: 212.472.2500

Email: info@vilcek.org

  • About
    • Our Mission
    • Board and Staff
    • Press Center
    • Contact
  • Prizes
    • Vilcek Prizes
    • Vilcek Prizes for Creative Promise
    • Vilcek Prize for Excellence
    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
  • Careers
Connect with us
  • Facebook
  • Instagram
  • Twitter
  • LinkedIn
  • Youtube
  • Vimeo
  • Privacy Policy
  • Accessibility Statement
© 2022   Vilcek Foundation